Brii Biosciences is committed to bringing innovative medicines to Chinese patients as a way to improve public health, and creating value for our partners as a way to improve their return on investment. We bring together clinically differentiated assets to meet this challenge, supported by world-class leadership, advisors, partners, and funders.
WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced today a strategic collaboration with Brii Biosciences……
Brii Biosciences, a company committed to serving patients’ needs and improving public health in China, today announced several research collaborations that significantly advance its efforts to develop innovative medicines to meet the unique needs of patients in China.
© 2018 Brii Biosciences, all rights reserved. Powered by ZiTYun